Polysaccharide-decorated nanoparticles

被引:400
作者
Lemarchand, C
Gref, R
Couvreur, P
机构
[1] Univ Paris 11, Fac Pharm, Sch Pharm, CNRS,UMR 8612, F-92926 Chatenay Malabry, France
[2] BioAlliance Pharma, Paris, France
关键词
nanoparticles; polysaccharide; surface modification; surface characterization; cancer therapy; tumour imaging; mucoadhesion; targeting;
D O I
10.1016/j.ejpb.2004.02.016
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Surface modified colloidal carriers such as nanoparticles are able to modulate the biodistribution of the loaded drug when given intravenously, but also to control the absorption of drugs administered by other routes. This review presents the different strategies to coat the surface of polymeric as well as inorganic nanoparticles with polysaccharides. Various physicochemical and biological methods have been described to demonstrate such surface modification. The medical applications, mainly in imaging cancer, of polysaccharide-coated nanoparticles are presented, including their abilities to increase the blood circulation time and to target specific tumoral tissues. It has been shown that these coatings allow also to improve drug absorption via nasal or ocular pathways, due the mucoadhesive and/or permeability enhancer properties of the poly saccharides. Finally, the ability of polysaccharide-coated nanoparticles to deliver DNA or oligonucleotides will be discussed. (C) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:327 / 341
页数:15
相关论文
共 111 条
[41]   SPECIFIC REJECTION OF GLYCOPHORIN-RECONSTITUTED LIPOSOMES BY HUMAN PHAGOCYTES [J].
GOTO, M ;
ARAKAWA, M ;
SATO, T ;
KONDO, H ;
SUNAMOTO, J .
CHEMISTRY LETTERS, 1987, (10) :1935-1938
[42]   Polysaccharides grafted with polyesters: Novel amphiphilic copolymers for biomedical applications [J].
Gref, R ;
Rodrigues, J ;
Couvreur, P .
MACROMOLECULES, 2002, 35 (27) :9861-9867
[43]   BIODEGRADABLE LONG-CIRCULATING POLYMERIC NANOSPHERES [J].
GREF, R ;
MINAMITAKE, Y ;
PERACCHIA, MT ;
TRUBETSKOY, V ;
TORCHILIN, V ;
LANGER, R .
SCIENCE, 1994, 263 (5153) :1600-1603
[44]  
Gref R., 2002, SYNTHESIS FUNCTIONAL, P233
[45]   New types of silica-fortified magnetic nanoparticles as tools for molecular biology applications [J].
Grüttner, C ;
Teller, J .
JOURNAL OF MAGNETISM AND MAGNETIC MATERIALS, 1999, 194 (1-3) :8-15
[46]  
GURNY R, 1987, Journal of Controlled Release, V6, P367, DOI 10.1016/0168-3659(87)90090-3
[47]   Improvement of MRI probes to allow efficient detection of gene expression [J].
Högemann, D ;
Josephson, L ;
Weissleder, R ;
Basilion, JP .
BIOCONJUGATE CHEMISTRY, 2000, 11 (06) :941-946
[48]   CHITOSAN AS A NOVEL NASAL DELIVERY SYSTEM FOR PEPTIDE DRUGS [J].
ILLUM, L ;
FARRAJ, NF ;
DAVIS, SS .
PHARMACEUTICAL RESEARCH, 1994, 11 (08) :1186-1189
[49]   SEQUESTRATION OF NEURAMINIDASE-TREATED ERYTHROCYTES - STUDIES ON ITS TOPOGRAPHIC, MORPHOLOGIC AND IMMUNOLOGICAL ASPECTS [J].
JANCIK, JM ;
SCHAUER, R ;
ANDRES, KH ;
VONDURING, M .
CELL AND TISSUE RESEARCH, 1978, 186 (02) :209-226
[50]   Polysaccharide colloidal particles as delivery systems for macromolecules [J].
Janes, KA ;
Calvo, P ;
Alonso, MJ .
ADVANCED DRUG DELIVERY REVIEWS, 2001, 47 (01) :83-97